CAH - Cardinal Health, Inc.
59.28 -0.07 (-0.12%)
After hours: 5:33PM EST
| Previous Close | 59.01 |
| Open | 58.90 |
| Bid | 59.03 x 800 |
| Ask | 60.20 x 900 |
| Day's Range | 58.66 - 59.37 |
| 52 Week Range | 41.03 - 60.69 |
| Volume | 1,862,464 |
| Avg. Volume | 2,534,414 |
| Market Cap | 17.317B |
| Beta (5Y Monthly) | 1.37 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -14.23 |
| Earnings Date | May 06, 2020 - May 10, 2020 |
| Forward Dividend & Yield | 1.92 (3.23%) |
| Ex-Dividend Date | Mar 30, 2020 |
| 1y Target Est | 58.43 |
- Zacks
Zacks.com featured highlights include: DaVita, Legg Mason, PG&E, Cardinal Health and McKesson
Zacks.com featured highlights include: DaVita, Legg Mason, PG&E, Cardinal Health and McKesson
- Investopedia
Drug Distributor Stocks in Focus on Opioid Settlement News
Leading drug distributor stocks remain sensitive to ongoing opioid settlement negotiations. Here are crucial technical levels to watch.
- Zacks
Here's Why You Should Invest in Cardinal Health Stock Now
Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment.
- Zacks
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now
DaVita (DVA) gains from solid results in the fourth quarter of 2019.
Reuters21 states reject $18 bln offer from U.S. distributors to settle opioid lawsuits - WSJ
Twenty one states reject an $18 billion settlement offer from three major drug distributors to resolve litigation over their alleged role in the opioid crisis, the Wall Street Journal reported on Friday, citing a letter sent to the companies' law firms earlier this week. The dissenting states want the companies - AmeriSourceBergen Corp, McKesson Corp and Cardinal Health Inc - to pay between $22 billion and $32 billion, WSJ reported https://on.wsj.com/37kSRkA, citing a person familiar with a matter. McKesson is focused on finalizing a global settlement structure that would provide billions of dollars in immediate funding and relief to states and local communities, a company spokesman said in an emailed statement.
- MarketWatch
Drug wholesaler stocks falls after WSJ report that states rejected opioid settlement offer
Shares of drug wholesalers, who have held talks to settle opioid litigation, sank in morning trading Friday, after The Wall Street Journal reported that 21 states had rejected an $18 billion settlement offer. Shares of AmerisourceBergen Corp. dropped 2.4%, Cardinal Health Inc. shed 2.5%, McKesson Corp. lost 1.4% and Johnson & Johnson fell 0.4%. In comparsion, the S&P 500 inched up less than 0.1%. The WSJ report, which cited a person familiar with the matter, said the dissenting states want the wholesalers to pay between $22 billion and $32 billion, for their alleged roles in contributing to the opioid crisis.
- Zacks
5 Great GARP Stocks Based on Discounted PEG
PEG-based investing can be more rewarding with the addition of a few other relevant parameters.
- Zacks
Will Cardinal Health Continue to Surge Higher?
As of late, it has definitely been a great time to be an investor in Cardinal Health.
- Thomson Reuters StreetEvents
Edited Transcript of CAH earnings conference call or presentation 6-Feb-20 1:30pm GMT
Q2 2020 Cardinal Health Inc Earnings Call
- PR Newswire
Cardinal Health Board of Directors Approves Quarterly Dividend
The Cardinal Health (NYSE: CAH) board of directors today approved a quarterly dividend of $0.4811 per share. The dividend will be payable on April 15, 2020, to shareholders of record at the close of business on April 1, 2020.
- Zacks
Has Cardinal Health (CAH) Outpaced Other Medical Stocks This Year?
Is (CAH) Outperforming Other Medical Stocks This Year?
- GuruFocus.com
Wall Street Opens Higher Monday
Loews jumps on fourth quarter results Continue reading...
- Zacks
5 Stocks to Watch as Fatalities Due to Coronavirus Rise
Coronavirus is ravaging China and several other countries. With no cure yet, health officials are struggling to stop its spread. Demand for medical supplies like masks is up manifold.
- Zacks
Ecolab's Eco-Flex Teat Dip to Boost Food & Beverage Segment
The Eco-Flex Teat Dip launch is likely to expand Ecolab's (ECL) Food & Beverage product portfolio.
- Zacks
Is Cardinal Health (CAH) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Zacks
Cardinal Health (CAH) in Focus: Stock Moves 10.6% Higher
Cardinal Health (CAH) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.
- Zacks
Cardinal (CAH) Hits 52-Week High, Can the Run Continue?
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- GuruFocus.com
Stock Market in the Green on Thursday
Bristol-Myers Squibb rises on 4th-quarter results Continue reading...
- Zacks
Cardinal Health (CAH) Q2 Earnings & Revenues Top Estimates
Cardinal Health (CAH) fiscal second-quarter results benefit revenue growth and strong segmental performance. However, contraction in gross margin remains a concern.
- Zacks
Cardinal Health (CAH) Q2 Earnings and Revenues Surpass Estimates
Cardinal (CAH) delivered earnings and revenue surprises of 25.62% and 0.64%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Should Cardinal Health, Inc. (NYSE:CAH) Be Part Of Your Dividend Portfolio?
Dividend paying stocks like Cardinal Health, Inc. (NYSE:CAH) tend to be popular with investors, and for good reason...
- Zacks
Medical Products Stock Feb 6 Earnings Roster: BDX, CAH & More
Despite the ongoing US-China trade war, increased focus on innovation is likely to have driven performance of medical products players' quarterly performance.
- Zacks
What's in Store for Cardinal Health's (CAH) Q2 Earnings?
Cardinal Health (CAH) fiscal second-quarter earnings are likely to reflect better-than-expected performance at Pharmaceutical and Medical segments.
- PR Newswire
Cardinal Health announces voluntary field actions for select procedure packs containing affected surgical gowns
Today, in continued coordination with the U.S. Food and Drug Administration (FDA), Cardinal Health announced it is initiating two voluntary field actions for select Cardinal Health Presource® Procedure Packs containing gowns that were part of last week's recall of AAMI Level 3 surgical gowns. These procedure packs, also known as kits, had been placed on voluntary hold at the time of the gown recall.
